HK Stock MarketDetailed Quotes

02157 LEPU BIO-B

Watchlist
  • 4.930
  • +0.230+4.89%
Trading Apr 26 13:00 CST
8.18BMarket Cap-328666P/E (TTM)

About LEPU BIO-B Company

Lepu Biotechnology Co., Ltd. is an innovative biopharmaceutical company based in China and focusing on the field of cancer treatment for the world. We have developed a strong product pipeline focusing on oncolog-focused drug candidates, including clinical and preclinical ADCs, oncolytic virus drugs, and immunotherapy. We plan to commercialize the product pipeline domestically by building a professional sales and marketing team, and promote the product pipeline to overseas markets such as the US and Europe through cooperation with overseas companies.

Company Profile

Symbol02157
Company NameLEPU BIO-B
ISINCNE100004SM4
Listing DateFeb 23, 2022
Issue Price7.13
Shares Offered126.88M share(s)
FoundedJan 19, 2018
Registered AddressChina
Chairmanzhongjie pu
Secretaryshaojuanliyunyi li
Audit InstitutionPricewaterhouseCoopers
Company CategoryOther
Registered Office2nd Floor, Building 41, No. 518, Xinzhuan Road, Songjiang District, Shanghai, China
Head Office and Principal Place of Business5/F, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees429
MarketHong Kong motherboard
Phone(021)67696099
Emailxueyou_bao@lepubiopharma.com
Websitehttp://www.lepubiopharma.com
Business Lepu Biotech Co., Ltd. is a Chinese biopharmaceutical company focused on the field of oncology treatment. The company mainly develops product pipelines for cancer candidates, including ADCs, oncolytic virus drugs, and immunotherapy in clinical and preclinical stages. The company's main research pipeline assets include MRG003, MRG002, HX008 and LP002, as well as three key clinical phase drug candidates. The company's products are sold to domestic and foreign markets.

Company Executives

  • Name
  • Position
  • Salary
  • zhongjie pu
  • Chairman，Executive Director，Chairman of the Strategy Committee，Remuneration and Evaluation Committee Member，Nomination Committee Members，Authorized Representative
  • --
  • ziye sui
  • general manager，Executive Director，Strategy Committee Members
  • --
  • jue pu
  • Non-executive directors，Audit Committee Members
  • --
  • hongbing yang
  • Non-executive directors
  • --
  • demin zhou
  • Independent Non-Executive Director，Chairman of the Nomination Committee，Strategy Committee Members
  • --
  • haifeng yang
  • Independent Non-Executive Director，Chairman of the Remuneration and Evaluation Committee，Audit Committee Members，Nomination Committee Members
  • --
  • fengmao hua
  • Independent Non-Executive Director，Chairman of the Audit Committee，Remuneration and Evaluation Committee Member
  • --
  • yang xu
  • auditors
  • --
  • ming yang
  • auditors
  • --
  • minmin qin
  • chief technology officer
  • --
  • lei fang
  • VP
  • --
  • lixuan zhao
  • Employee representative supervisor
  • --
  • geman li
  • VP
  • --
  • yunyi li
  • Chief Financial Officer，Joint Company Secretary，Board Secretary
  • --
  • shaojuan li
  • Joint Company Secretary，Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg